Reduced or suppressed expression associated with methylation of the Pcdh10 promoter has been described in numerous human cancers, including multiple myeloma, gastric cancer (GC), prostate cancer and cervical cancer, where restoration of expression inhibited cell growth and migration [73,74,75,76]. The gene discussed is PCDH10; the disease is prostate cancer.